Management issues challenge biotech startups This article reviews a very interesting report that basically faults the failure of biotechnology companies […]

Monsanto: Ready to Blossom? Shifting the focus from farm chemicals to the more lucrative gene-altered seeds hasn’t been easy, but

FDA big factor behind high US drug costs The U.S. Food and Drug Administration, with its costly and time-consuming drug

FDA Begins Push to End Drug Imports A second ‘blitz’ inspection by federal drug and customs officials of medicines imported

What To Expect From A Venture Capitalist The more important question is, ‘What can I expect out of a good

Is ImClone Out of the Woods? If the FDA approves its Erbitux anticancer treatment, as S&P expects, the biotech’s volatile

What’s in a Drug Name? Did you ever wonder at the bizarre brand names born by your favorite medicines? If

What’s in a Drug Name? Did you ever wonder at the bizarre brand names born by your favorite medicines? If

Rise in biotech lawsuits Biotech companies were served with 17 percent of all U.S. shareholder suits last year, according to

Agriculture Department looks at revamping biotech rules Worried about the inadvertent spread of new bioengineered plants that produce drugs and